Timothy Van Hauwermeiren Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Timothy Van Hauwermeiren is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 10,632 shares of DNLI, which is worth approximately $185,422. The most recent transaction as insider was on Nov 04, 2025, when has been sold 10,632 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.6K
n/a 3M change
n/a 12M change
Total Value Held $185,422

Timothy Van Hauwermeiren Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 04 2025
BUY
Grant, award, or other acquisition
-
10,632 Added 50.0%
10,632 Common Stock

Also insider at

ITOS
iTeos Therapeutics, Inc. Healthcare
RYZB
RayzeBio, Inc.
LXEO
Lexeo Therapeutics, Inc.
TVH

Timothy Van Hauwermeiren

Director
Watertown, MA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI